- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03921853
Resistance Training in Patients With Morbid Obesity (ExinMO)
Preventing Metabolic Syndrome in Patients With Morbid Obesity by Resistance Training: Reporting Non-responder Prevalence
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The prevalence of metabolic syndrome (MetS) and cardiovascular disease is expected to rise along with the global obesity epidemic. MetS is a cluster of clinical risk factors, including abdominal (visceral) obesity, hypertension, elevated serum triglycerides, low serum high-density lipoprotein (HDL) and hyperglycaemia.The MetS for example, significantly decreases the life expectancy of individuals with morbid obesity and increases the disease burden and economic costs associated with healthcare. In this sense, more recently, there was reported that body mass index (BMI) and fat distribution showed higher associations with inflammation, fat indices, and more prevalence of MetS in morbidly obese subjects, claiming for an early prevention of the MetS in the morbid obese state.
Exercise training has proven to be effective in inducing a clinically significant weight loss and reducing cardiovascular risk. Exercise have reported to be associated with increased muscle mass, decreased body fat, and improved metabolic profile (i.e., improved glucose control and lipid levels). In addition, supervised RT improved muscle strength and functional capacity in patients with obesity undergoing bariatric surgery. However, although RT has been widely studied in obesity, there is little information in the morbid obesity. On the other hand, there is poor knowledge similarly, about the interindividual variability to exercise training in terms of responders and non-responders (NR). Thus, considering the poor knowledge about the MetS prevention in morbid obese patients, as well as the little information about Responders and Non-Responders for improving MetS outcomes, the aim of this study will be determine the effects of a RT program on cardio-metabolic outcomes of MetS in patients with morbid obesity. A second aim will be report the prevalence of non-responders in terms of the effects of resistance training on MetS markers and other health-related variables.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Llanquihue
-
Osorno, Llanquihue, Chile, 5290000
- Cristian ALvarez
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
Inclusion Criteria:
- Older than 18 and younger and ≤65 years of age.
- With risk factors to Metabolic syndrome
- With obesity and morbid obesity condition
- Medical authorization by a physician.
Exclusion Criteria:
- Physical limitations (e.g., restricting injuries of the musculoskeletal system, or dependent of a third person).
- Exercise-related dyspnoea or respiratory alterations.
- Chronic heart disease with any worsening in the last month.
- Adherence rate of less than 80% of the total interventions.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Active comparator
Control group with obesity under Resistant Training
|
The 20-week RT program will consist of three sessions per week, each lasting for 1 hour that will be applied to both control obese (CG) and morbid obese (MO) group.
All sessions will start with 15 minutes warm-up with continuous walking and joint mobility and flexibility exercises, 5 minutes of cool down and stretching, in order for preventing injuries.
Sessions will include 4 to 8 RT exercises targeting different muscle groups; 1. forearm, 2. knee flexors and 3. extensors, 3. trunk, 4. chest, 5. shoulder elevators, 6. horizontal shoulder flexors and 7. extensors, and 8. plantar flexors.
The exercises for each muscle group will be performed in 3 sets of as many repetitions (continuous concentric/eccentric voluntary contraction) possible in 1 minute followed by 2.0 minutes of passive recovery.
Before the RT program, each participant will be measure using the subjective modified Borg scale (1-10 points), in order of identifying the muscle failure into 1 minute of exercise.
Andere Namen:
|
|
Experimental: Experimental group with morbid obesity
Experimental group with morbid obesity under Resistant Training
|
The 20-week RT program will consist of three sessions per week, each lasting for 1 hour that will be applied to both control obese (CG) and morbid obese (MO) group.
All sessions will start with 15 minutes warm-up with continuous walking and joint mobility and flexibility exercises, 5 minutes of cool down and stretching, in order for preventing injuries.
Sessions will include 4 to 8 RT exercises targeting different muscle groups; 1. forearm, 2. knee flexors and 3. extensors, 3. trunk, 4. chest, 5. shoulder elevators, 6. horizontal shoulder flexors and 7. extensors, and 8. plantar flexors.
The exercises for each muscle group will be performed in 3 sets of as many repetitions (continuous concentric/eccentric voluntary contraction) possible in 1 minute followed by 2.0 minutes of passive recovery.
Before the RT program, each participant will be measure using the subjective modified Borg scale (1-10 points), in order of identifying the muscle failure into 1 minute of exercise.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Fasting glucose
Zeitfenster: Change from Baseline Fasting glucose at 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
Change from Baseline Fasting glucose at 20-weeks of Resistant Training
|
|
High density lipoprotein
Zeitfenster: Change from Baseline High density lipoprotein at 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
Change from Baseline High density lipoprotein at 20-weeks of Resistant Training
|
|
Systolic blood pressure and diastolic blood pressure
Zeitfenster: from Baseline Systolic blood pressure and diastolic blood after 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
from Baseline Systolic blood pressure and diastolic blood after 20-weeks of Resistant Training
|
|
Waist circumference
Zeitfenster: Change from Baseline Waist circumference at 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
Change from Baseline Waist circumference at 20-weeks of Resistant Training
|
|
Triglycerides
Zeitfenster: Change from Baseline Triglycerides at 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
Change from Baseline Triglycerides at 20-weeks of Resistant Training
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Body mass index
Zeitfenster: Change from Baseline Body mass index at 20-weeks of Resistant Training
|
Anthropometric
|
Change from Baseline Body mass index at 20-weeks of Resistant Training
|
|
Body mass
Zeitfenster: Change from Baseline Body mass at 20-weeks of Resistant Training
|
Anthropometric
|
Change from Baseline Body mass at 20-weeks of Resistant Training
|
|
Total cholesterol
Zeitfenster: Change from Baseline Total cholesterol at 20-weeks of Resistant Training
|
Measured by plasma sample
|
Change from Baseline Total cholesterol at 20-weeks of Resistant Training
|
|
Low density lipoprotein
Zeitfenster: Change from Baseline Low density lipoprotein at 20-weeks of Resistant Training
|
Measured by plasma sample
|
Change from Baseline Low density lipoprotein at 20-weeks of Resistant Training
|
|
Six minutes walking test
Zeitfenster: Change from Baseline Six minutes walking test density lipoprotein at 20-weeks of Resistant Training
|
Endurance performance
|
Change from Baseline Six minutes walking test density lipoprotein at 20-weeks of Resistant Training
|
|
One maximum repetition of biceps curl
Zeitfenster: Change from Baseline One maximum repetition of biceps curl at 20-weeks of Resistant Training
|
Strength Performance
|
Change from Baseline One maximum repetition of biceps curl at 20-weeks of Resistant Training
|
|
Handgrip muscle strength
Zeitfenster: Change from Baseline Handgrip muscle strength at 20-weeks of Resistant Training
|
Muscle strength
|
Change from Baseline Handgrip muscle strength at 20-weeks of Resistant Training
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Studienleiter: Cristian ALvarez, PhD, Universidad de Los Lagos
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- RP08042019
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .